Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
